Sandra Jarva Weiss, Chair of the Norris McLaughlin Health Care & Life Sciences Law Practice Group, has been practicing health care law for over 30 years and has extensive experience in all areas of health care regulation. She has designed numerous compliance programs, and counsels clients on compliance with the Anti-Kickback Statute and the Stark Statute. Sandra has counseled clients on federal and state patient privacy laws, as well as Medicare and Medicaid reimbursement requirements. She has extensive practical experience, having served as in-house counsel for a large teaching hospital system.
Sandra’s experience includes regulatory compliance, mergers, acquisitions, strategic affiliations of health and health-related businesses, and developing corporate compliance plans for health care entities. She is experienced in structuring the development of entities, such as imaging centers and ambulatory surgical centers. Sandra has handled physician contracts, employment agreements, medical staff grievance proceedings, disciplinary proceedings, and termination proceedings. She is well-versed in HIPAA privacy compliance, compliance with Joint Commission standards, managed care contracting for hospitals and medical providers, physician-hospital organization contracts, clinical trial agreements, and corporate work for health care institutions, such as lease and supply agreements.
Sandra’s clients include hospitals, physician groups, health care providers, medical device and equipment companies, PHOs, management service organizations, foundations, rehabilitation centers, and pharmaceutical companies. She also assists clients in the ongoing education and training of their employees in compliance with applicable health care regulations.
Sandra Jarva Weiss Named to School of American Ballet Advisory Council
Sandra Jarva Weiss Presents to MidAtlantic College Nurses Association
Sandra Jarva Weiss Speaks on Health Care Reform at Lafayette College
Sandra Jarva Weiss Promoted to Chair of Pennsylvania Office Health Care Group
Sandra Jarva Weiss Elected to Board of Directors of the State Theatre Center for the Arts
PHARMA MANUFACTURERS IMPACTED BY NEW LIMITS ON PAYMENTS AND GIFTS TO NJ PRESCRIBERS
COURT ORDERS DIVESTITURE OF ST. LUKE’S ACQUISITION OF A PHYSICIAN PRACTICE GROUP
THE MEDICAL PROFESSION BEWARE: THE FALSE CLAIMS ACT – A DANGER YOU CAN'T IGNORE
See MoreOSHA Issues COVID-19 Safety Rule: Emergency Temporary Standard (ETS)
Impact of the COVID Pandemic on Physician Employment Agreements
Extensive Changes to Stark and Anti-Kickback Regulations
HHS Modifies COVID-19 Provider Relief Fund Eligibility and Reporting Requirements
OIG Work Plan Updates Related to COVID-19
DEADLINES LOOM FOR HHS ALLOCATION OF $100 BILLION CARES ACT RELIEF FUND FOR HEALTH CARE PROVIDERS
CARES Act Provides Financial Relief for Health Care Providers
Senate Approves $100 Billion to Hospitals in COVID-19 Relief Package
CMS’s Growing Interest in Value-Based Payments
CMS Issues Proposed Rule on Stark Law Advisory Opinions
The Targeting of Private Medical Office Data
When a Patient Refuses to Listen to Their Doctor
Need for Academic Medical Centers to Change Model
DOJ Recovers $2.8 Billion in 2018 False Claims Act Cases
Consequences for HIPAA Violations Don’t Stop When a Business Closes
Continued Uncertainty of Provider-Based Status in Space Sharing Arrangements
IMPAIRED PHYSICIANS – Health Care Counsel Can Help Navigate the Rough Waters
The Dangers of a Medical Board Investigation: How to Protect Yourself
OIG Video on Corporate Integrity Agreements
Medical Executive Committees Have the Capacity to Sue or Be Sued in New Jersey
When Performing Employee Exclusion Checks, Check Both LEIE and the GSA Debarred Individuals List
See More